Molecular subtyping of small cell lung cancer to predict therapeutic responses

Abstract

1 . A method of classifying a patient having a small cell lung cancer, the method comprising: (a) obtaining a sample of the patient's cancer; (b) measuring an expression level of ASCL1, NEURON, and POU2F3 in the sample or determining a methylation status of ASCL1, NEURON, and POU2F3 in the sample;